Quinnova Pharmaceuticals, Inc. — Form D
Quinnova Pharmaceuticals, Inc. of NEWTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2009-11-04. The offering totals $17.4M, of which $17.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-11-04
- Form: D
- Accession: 0001383572-09-000004
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $17.4M
- Amount sold: $17.4M
- Investors: 18
- Date of first sale: 2009-10-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-97375
Issuer
- Name: Quinnova Pharmaceuticals, Inc.
- CIK: 0001383572
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: 411 S. STATE STREET, NEWTOWN, PA, 18940
- Phone: 215-860-6263
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Al Thomas Altomari | Director | Newtown, PA |
| James Thomas Datin | Director | Newtown, PA |
| Aaron Frits Davidson | Director | Miami, FL |
| Jeffrey S Day | Director | Newtown, PA |
| Brian M Gallagher | Director | Cambridge, MA |
| Lincoln Thomas Krochmal | Director | Newtown, PA |
| Alex Frits Zisson | Director | Stamford, CT |
| Jeffrey S Day | Executive Officer | Newtown, PA |
| Duane J Napolitana | Executive Officer | Newtown, PA |
| Jeffrey S Day | Promoter | Newtown, PA |
| James A Datin | Director | Cobourg, A6 |
| Brian M Gallagher | Executive Officer | Cambridge, MA |
| Aaron A Davidson | Director | Newtown, PA |
| G. Frits Besselaar | Director | Newtown, PA |
| Alex M Zisson | Director | Newtown, PA |
Other filings by this issuer (2)
More